Akèy › Maladi Greff-versus-host › Washington
Etid klinik pou Maladi Greff-versus-host nan Washington, DC
5 etid pou Maladi Greff-versus-host ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Ap rekriteFaz 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Evaluation of Patients With Immune Function Abnormalities
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
Ap rekriteFaz 2
- National Institute of Health (Data Collection AND Specimen Analysis), Bethesda · 7 mi lwen
Etid Maladi Greff-versus-host nan lòt vil
- Boston, MA10 etid
- New York City, NY7 etid
- Columbus, OH6 etid
- Baldwin Park, CA5 etid
- Atlanta, GA5 etid
- Pittsburgh, PA4 etid
- Detroit, MI4 etid
- Portland, OR4 etid
- St. Louis, MO4 etid
- Tampa, FL4 etid
- Seattle, WA4 etid
- Miami, FL4 etid
Lòt etid nan Washington
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil55 etid
- Kansè nan tete46 etid
- Kansè Metastatik43 etid
- Kansè poumon41 etid
- Kansè pwostat38 etid
- Obèsite33 etid
- Kansè kolorektal29 etid
- Maladi kadyovaskilè28 etid
- Kansè vejik26 etid
- Leksemi mieloïd egi24 etid
- Kansè ovè23 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.